Literature DB >> 10786751

Aerosolized surfactant in lung-lavaged adult rats: factors influencing the therapeutic response.

H Bahlmann1, B Sun, G Nilsson, T Curstedt, B Robertson.   

Abstract

OBJECTIVE: To evaluate the effect of aerosolized modified natural surfactant in adult rats with respiratory failure.
METHODS: Lung-lavaged adult rats were treated with aerosolized surfactant, aerosolized saline or a bolus of surfactant. Surfactant was labelled with dimyristoylphosphatidylcholine (DMPC) and human serum albumin was given intravenously for evaluation of lung protein leakage. Blood gases and dynamic compliance were measured intermittently. At the end of ventilation, the lungs were either fixed by vascular perfusion for histological examination or washed for determination of total phospholipids, DMPC and human albumin in the lavage fluid.
RESULTS: Treatment with bolus surfactant led to a quick and sustained restoration of pre-lavage blood gas values in most animals. The response to aerosolized surfactant varied considerably, with an overall moderate improvement of gas exchange. The saline-treated group failed to show any significant recovery of lung function. No histopathological differences were found between any of the groups. On average 0.46% of total administered aerosolized surfactant could be recovered. Vascular-to-alveolar leakage of human albumin averaged 11%, with no significant differences between the groups. Final values for PaO2 were significantly correlated with total phospholipids in the lavage fluid, and inversely related to the vascular-to-alveolar leakage of albumin.
CONCLUSION: Neither bolus nor aerosolized surfactant influenced lung morphology. Nebulized surfactant improved lung function but the effect was inferior to that obtained with bolus surfactant, and the outcome depended on the balance between the combined pool size of exogenous and endogenous surfactant and the vascular-to-alveolar leakage of serum protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786751     DOI: 10.1034/j.1399-6576.2000.00521.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

Review 1.  Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Authors:  Emmanuel Lopez; Géraldine Gascoin; Cyril Flamant; Mona Merhi; Pierre Tourneux; Olivier Baud
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

2.  Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome.

Authors:  Francesca Ricci; Chiara Catozzi; Xabier Murgia; Brenda Rosa; Davide Amidani; Luca Lorenzini; Federico Bianco; Claudio Rivetti; Silvia Catinella; Gino Villetti; Maurizio Civelli; Barbara Pioselli; Carlo Dani; Fabrizio Salomone
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 3.  Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.

Authors:  Federico Bianco; Fabrizio Salomone; Ilaria Milesi; Xabier Murgia; Sauro Bonelli; Elena Pasini; Raffaele Dellacà; Maria Luisa Ventura; Jane Pillow
Journal:  Respir Res       Date:  2021-02-26

Review 4.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19.

Authors:  Lore Herman; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2021-11-20       Impact factor: 9.776

5.  Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats.

Authors:  Yu Sun; Rui Yang; Ji-gen Zhong; Feng Fang; Jin-jin Jiang; Ming-yao Liu; Jian Lu
Journal:  Crit Care       Date:  2009-03-04       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.